In-Vitro Colorectal Cancer Screening Tests Market to see growth of over 5.0% from 2017 to 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

In-Vitro Colorectal Cancer Screening Tests Market to see growth of over 5.0% from 2017 to 2024

Description:

Get more details @ Growing incidences of colorectal cancer globally along with rising disease awareness due to numerous initiatives undertaken by public and private players will drive in-vitro colorectal cancer screening tests market. – PowerPoint PPT presentation

Number of Views:49

less

Transcript and Presenter's Notes

Title: In-Vitro Colorectal Cancer Screening Tests Market to see growth of over 5.0% from 2017 to 2024


1
In-Vitro Colorectal Cancer Screening Tests Market
to reach 1bn by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from In-vitro Colorectal Cancer
Screening Tests Market
  • In-Vitro Colorectal Cancer Screening Tests Market
    size is set to exceed USD 1 billion by 2024
    according to a new research report by Global
    Market Insights.
  • The colorectal cancer screening has revealed to
    be effective technique in order to detect early
    colorectal cancer (CRC) as well as precancerous
    lesions.
  • Chronic conditions such as inflammatory bowel
    disease, and Type 2 diabetes along with sedentary
    lifestyle, heavy alcohol consumption is on
    escalation and are related to colorectal cancer.
  • Inadequate reimbursement coverage coupled with
    lack of trained staff in the developing regions
    and dearth of uniform cancer screening guidelines
    in the Asia Pacific region will hamper business
    growth.
  • Fecal occult blood test (FOBT) test type segment
    dominated the market in 2016, on an account of
    widely preferred test due to FOBT being
    inexpensive and non-invasive as compared to
    sigmoidoscopy and colonoscopy.

3
Continued...
  • CRC DNA screening test segment is anticipated to
    grow at a highest CAGR.
  • Germany in-vitro colorectal cancer screening
    tests market is projected to witness robust
    business growth in foreseeable future.
  • Italy in-vitro CRC screening tests market is
    anticipated to exhibit highest CAGR due to
    increasing risk factors of cancer, coupled with
    growing elderly population base.
  • Chinas in-vitro colorectal cancer screening
    tests market will grow significantly as a result
    of escalating incidences of colorectal cancer and
    growing initiatives by government for
    establishing targeted prevention and prior
    detection programs.
  • Some of the prominent business players
    operational in global in-vitro CRC screening
    tests market are Alere, Abbott Molecular, Eiken
    Chemical, Beckman Coulter, Epigenomics, Siemens
    Healthcare, Sysmex, Quest Diagnostics, Exact
    Sciences, OncoCyte Corporation-Bio time, EMD
    Millipore, GeneNews, BioMarCare Technologies,
    Immunostics, Qiagen, Kyowa Medex, Novigenix,
    Randox Laboratories, and R-Biopharm.

4
China In-Vitro Colorectal Cancer Screening Tests
Market, By Test Type, 2013 - 2024 (USD Million)

5

Browse Full Market Research Report On In-vitro
Colorectal Cancer Screening Tests Market _at_
http//goo.gl/JHtO1Z Request for a Sample of
this Research Report _at_ https//www.gminsights.com/
request-sample/detail/451 https//www.gminsights.
com/request-sample/detail/49
6
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com